Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ABBV NASDAQ:AVGO NYSE:PG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$210.54-0.1%$210.27$180.25▼$244.81$371.72B0.326.84 million shs5.36 million shsAVGOBroadcom$425.19-3.3%$365.61$221.60▼$442.36$2.01T1.4319.35 million shs18.89 million shsPGProcter & Gamble$141.68-0.7%$146.10$137.62▼$170.99$329.66B0.418.99 million shs6.98 million shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie0.00%+4.62%+0.74%-9.08%+18.75%AVGOBroadcom0.00%-1.12%+6.71%+30.76%+83.18%PGProcter & Gamble0.00%-3.25%-1.03%-11.51%-10.48%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$210.54-0.1%$210.27$180.25▼$244.81$371.72B0.326.84 million shs5.36 million shsAVGOBroadcom$425.19-3.3%$365.61$221.60▼$442.36$2.01T1.4319.35 million shs18.89 million shsPGProcter & Gamble$141.68-0.7%$146.10$137.62▼$170.99$329.66B0.418.99 million shs6.98 million shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie0.00%+4.62%+0.74%-9.08%+18.75%AVGOBroadcom0.00%-1.12%+6.71%+30.76%+83.18%PGProcter & Gamble0.00%-3.25%-1.03%-11.51%-10.48%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABBVAbbVie 2.88Moderate Buy$253.4320.37% UpsideAVGOBroadcom 2.94Moderate Buy$441.633.87% UpsidePGProcter & Gamble 2.55Moderate Buy$161.0613.68% UpsideCurrent Analyst Ratings BreakdownLatest AVGO, PG, and ABBV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2026ABBVAbbVie EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$235.005/15/2026AVGOBroadcom TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$405.00 ➝ $500.005/14/2026ABBVAbbVie Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$294.00 ➝ $298.005/14/2026AVGOBroadcom Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$430.00 ➝ $545.005/12/2026AVGOBroadcom CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$475.00 ➝ $500.005/1/2026ABBVAbbVie GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$249.004/30/2026ABBVAbbVie DZ BankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy4/30/2026ABBVAbbVie Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$262.00 ➝ $265.004/30/2026ABBVAbbVie Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$270.00 ➝ $278.004/30/2026ABBVAbbVie Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$240.004/30/2026ABBVAbbVie Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeNeutral ➝ Buy$234.00(Data available from 5/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABBVAbbVie$61.16B6.08$15.16 per share13.89($3.74) per share-56.29AVGOBroadcom$63.89B31.51$7.70 per share55.19$17.15 per share24.79PGProcter & Gamble$84.28B3.91$8.37 per share16.92$23.18 per share6.11Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABBVAbbVie$4.23B$2.03103.7112.920.735.79%-576.45%13.39%7/30/2026 (Estimated)AVGOBroadcom$23.13B$5.1283.0526.040.8836.57%38.61%17.49%6/3/2026 (Estimated)PGProcter & Gamble$15.97B$6.8420.7119.986.0719.16%32.00%13.27%8/4/2026 (Estimated)Latest AVGO, PG, and ABBV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/3/2026Q2 2026AVGOBroadcom$2.40N/AN/AN/A$22.04 billionN/A4/29/2026Q1 2026ABBVAbbVie$2.59$2.65+$0.06$0.39$14.72 billion$15.00 billion4/24/2026Q3 2026PGProcter & Gamble$1.56$1.59+$0.03$1.63$21.52 billion$21.24 billion3/4/2026Q1 2026AVGOBroadcom$2.03$2.05+$0.02$1.50$19.10 billion$19.31 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthABBVAbbVie$6.923.29%+6.80%340.89%53 YearsAVGOBroadcom$2.600.61%+12.67%50.78%15 YearsPGProcter & Gamble$4.353.07%+6.13%63.60%70 YearsLatest AVGO, PG, and ABBV DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/19/2026ABBVAbbViequarterly$1.733.32%4/15/20264/15/20265/15/20264/14/2026PGProcter & Gamblequarterly$1.08852.94%4/24/20264/24/20265/15/20263/3/2026AVGOBroadcomQuarterly$0.650.81%3/23/20263/23/20263/31/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABBVAbbVieN/A0.800.56AVGOBroadcom0.801.901.73PGProcter & Gamble0.440.730.53Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABBVAbbVie70.23%AVGOBroadcom76.43%PGProcter & Gamble65.77%Insider OwnershipCompanyInsider OwnershipABBVAbbVie0.06%AVGOBroadcom1.90%PGProcter & Gamble0.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABBVAbbVie57,0001.77 billion1.77 billionOptionableAVGOBroadcom33,0004.73 billion4.64 billionOptionablePGProcter & Gamble109,0002.33 billion2.32 billionOptionableAVGO, PG, and ABBV HeadlinesRecent News About These CompaniesProcter & Gamble Company (The) (NYSE:PG) Given Average Recommendation of "Moderate Buy" by Brokerages29 minutes ago | americanbankingnews.comProcter & Gamble Company (The) (NYSE:PG) Receives Average Rating of "Moderate Buy" from Brokerages32 minutes ago | marketbeat.comTrade Wars Come and Go. These 2 Consumer Staples Stocks Are Built to Last.May 16 at 8:15 AM | fool.comLawood & Co. Takes $1.18 Million Position in Procter & Gamble Company (The) $PGMay 16 at 6:40 AM | marketbeat.comLockheed Martin Investment Management Co. Has $12.22 Million Position in Procter & Gamble Company (The) $PGMay 16 at 6:11 AM | marketbeat.comDNB Asset Management AS Acquires 123,713 Shares of Procter & Gamble Company (The) $PGMay 16 at 4:32 AM | marketbeat.comCommerzbank Aktiengesellschaft FI Has $83.43 Million Position in Procter & Gamble Company (The) $PGMay 16 at 4:31 AM | marketbeat.comBessemer Group Inc. Reduces Holdings in Procter & Gamble Company (The) $PGMay 16 at 4:22 AM | marketbeat.comHow Ranch Dressing Took Over America (And Failed Everywhere Else)May 15 at 6:50 PM | youtube.comYWhy Keeping Emergency Cash in Checking Costs You $15,000 Over a DecadeMay 15 at 6:50 PM | 247wallst.comCongressman A Big Fan Of Dividend Reinvestments: Here's His Core Blue Chip StocksMay 15 at 2:46 PM | benzinga.comWhat Retirement Really Looks Like at 64 With $2.4 Million and a Father Moving Into the Guest Room Next YearMay 15 at 1:49 PM | 247wallst.comSummit Wealth Group LLC Co. Sells 9,550 Shares of Procter & Gamble Company (The) $PGMay 15 at 5:40 AM | marketbeat.comConning Inc. Grows Position in Procter & Gamble Company (The) $PGMay 15 at 4:13 AM | marketbeat.com166,576 Shares in Procter & Gamble Company (The) $PG Purchased by Arbejdsmarkedets TillaegspensionMay 15 at 3:16 AM | marketbeat.comForget UnitedHealth: Two Stocks To Buy NowMay 14 at 1:13 PM | 247wallst.comProcter & Gamble Company (The) $PG Shares Sold by VIRGINIA RETIREMENT SYSTEMS ET AlMay 14 at 7:07 AM | marketbeat.comPlancorp LLC Has $3.23 Million Stock Holdings in Procter & Gamble Company (The) $PGMay 14 at 6:27 AM | marketbeat.comRayburn West Financial Services LLC Takes Position in Procter & Gamble Company (The) $PGMay 14 at 6:06 AM | marketbeat.comProcter & Gamble Company (The) $PG Shares Acquired by Madison Asset Management LLCMay 14 at 5:21 AM | marketbeat.comCatalyst Financial Partners LLC Trims Stock Position in Procter & Gamble Company (The) $PGMay 14 at 3:57 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThis AI Lender Has Big Upside Potential—And Big Risks By Peter Frank | April 19, 2026Big-Tech Earnings: Google and Meta's Results Support Broadcom's OutlookBy Leo Miller | May 4, 2026MaxLinear’s Explosive 200% Rally Looks Impressive—But Can It Last?By Dan Schmidt | May 1, 2026Procter & Gamble Gave the Market What It Wanted: A Reason to BuyBy Thomas Hughes | April 24, 2026Monolithic Power Systems: AI Stock Beat, Raised and Upgraded Post-EarningsBy Leo Miller | May 5, 2026AVGO, PG, and ABBV Company DescriptionsAbbVie NYSE:ABBV$210.54 -0.23 (-0.11%) Closing price 05/15/2026 03:59 PM EasternExtended Trading$210.80 +0.26 (+0.12%) As of 05/15/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.Broadcom NASDAQ:AVGO$425.19 -14.60 (-3.32%) Closing price 05/15/2026 04:00 PM EasternExtended Trading$423.48 -1.71 (-0.40%) As of 05/15/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Broadcom Inc. designs, develops, and supplies various semiconductor devices with a focus on complex digital and mixed signal complementary metal oxide semiconductor based devices and analog III-V based products worldwide. The company operates in two segments, Semiconductor Solutions and Infrastructure Software. It provides set-top box system-on-chips (SoCs); cable, digital subscriber line, and passive optical networking central office/consumer premise equipment SoCs; wireless local area network access point SoCs; Ethernet switching and routing custom silicon solutions; serializer/deserializer application specific integrated circuits; optical and copper, and physical layer devices; and fiber optic components and RF semiconductor devices. The company also offers RF front end modules and filter; Wi-Fi, Bluetooth, and global positioning system/global navigation satellite system SoCs; custom touch controllers; inductive charging; attached small computer system interface, and redundant array of independent disks controllers and adapters; peripheral component interconnect express; fiber channel host bus adapters; read channel based SoCs; custom flash controllers; preamplifiers; optocouplers, industrial fiber optics, and motion control encoders and subsystems; light emitting diode, ethernet PHYs, switch ICs, and camera microcontrollers. Its products are used in various applications, including enterprise and data center networking, home connectivity, set-top boxes, broadband access, telecommunication equipment, smartphones and base stations, data center servers and storage systems, factory automation, power generation and alternative energy systems, and electronic displays. Broadcom Inc. was founded in 1961 and is headquartered in Palo Alto, California.Procter & Gamble NYSE:PG$141.68 -1.03 (-0.72%) Closing price 05/15/2026 03:59 PM EasternExtended Trading$141.65 -0.03 (-0.02%) As of 05/15/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Peloton Stock Gives Back Gains After Upbeat Earnings Report MarketBeat Week in Review – 05/11 - 05/15 Datavalut Gains Traction: 5 Reasons to Sell Now TMC Stock: Why This Pre-Revenue Miner Is Worth Watching Alphabet's Googlebook Brings Gemini AI to PC Hardware Viking Sails to All-Time Highs—Fundamentals Signal More to Come YETI Rallies After Earnings Beat and Raised Outlook Aeluma's Post-Earnings Dip Creates a Buying Opportunity Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
